Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Intranasal Bevacizumab for HHT-Related Epistaxis
Trial ID or NCT#
NCT02389959
Status
RECRUITING
Purpose
This is a randomized, controlled, double-blind, placebo-controlled trial of intranasal Avastin (bevacizumab) injection versus saline control for control of HHT-related epistaxis when used in conjunction with bipolar electrocautery.
Official Title
Intranasal Bevacizumab for HHT-Related Epistaxis
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- 1. The patient carries a diagnosis of hereditary hemorrhagic telangiectasia (HHT)
- 2. The patient is to undergo treatment with electrocautery in the operating room under endoscopic visualization
- 3. The patient is able to give informed consent
- 4. The patient is at least 18 years old
Exclusion Criteria:
- 1. The patient has had prior treatment with systemic or nasal bevacizumab within the past year
- 2. The patient has undergone electrocautery for epistaxis within the 6 months prior to study enrollment
- 3. The patient is a minor
- 4. The patient is pregnant
- 5. The patient is incapable of understanding the consent process
- 6. The patient has a history of HIV or another known cause of immunosuppression, or is actively taking immunosuppressive medications due to organ transplantation, rheumatoid disease, or other medical conditions.
Investigator(s)
Peter H. Hwang
Rhinologist,
Otolaryngologist
Professor of Otolaryngology - Head and Neck Surgery (Rhinology) and, by courtesy, of Neurosurgery at the Stanford University Medical Center
Contact us to find out if this trial is right for you.
CONTACT
Amelia K Clark, MD
View on ClinicalTrials.gov
About this Clinical Trial
Intranasal Bevacizumab for HHT-Related Epistaxis